Abstract
Gene expression in all organisms is controlled by cooperative interactions between DNA-bound transcription factors (TFs), but quantitatively measuring TF-DNA and TF-TF interactions remains difficult. Here we introduce a strategy for precisely measuring the Gibbs free energy of such interactions in living cells. This strategy centers on the measurement and modeling of ‘allelic manifolds’, a multidimensional generalization of the classical genetics concept of allelic series. Allelic manifolds are measured using reporter assays performed on strategically designed cis-regulatory sequences. Quantitative biophysical models are then fit to the resulting data. We used this strategy to study regulation by two Escherichia coli TFs, CRP and RNA polymerase. Doing so, we consistently obtained energetic measurements precise to kcal/mol. We also obtained multiple results that deviate from the prior literature. Our strategy is compatible with massively parallel reporter assays in both prokaryotes and eukaryotes, and should therefore be highly scalable and broadly applicable.
Editorial note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that minor issues remain unresolved (see decision letter).
Research organism: E. coli
Introduction
Cells regulate the expression of their genes in response to biological and environmental cues. A major mechanism of gene regulation in all organisms is the binding of transcription factor (TF) proteins to cis-regulatory elements encoded within genomic DNA. DNA-bound TFs interact with one another, either directly or indirectly, forming cis-regulatory complexes that modulate the rate at which nearby genes are transcribed (Ptashne and Gann, 2002; Courey, 2008). Different arrangements of TF binding sites within cis-regulatory sequences can lead to different regulatory programs, but the rules that govern which arrangements lead to which regulatory programs remain largely unknown. Understanding these rules, which are often referred to as ‘cis-regulatory grammar’ (Spitz and Furlong, 2012), is a major challenge in modern biology.
Measuring the quantitative strength of interactions among DNA-bound TFs is critical for elucidating cis-regulatory grammar. In particular, knowing the Gibbs free energy of TF-DNA and TF-TF interactions is essential for building biophysical models that can quantitatively explain gene regulation in terms of simple protein-DNA and protein-protein interactions (Shea and Ackers, 1985; Bintu et al., 2005; Sherman and Cohen, 2012). Biophysical models have proven remarkably successful at quantitatively explaining regulation by a small number of well-studied cis-regulatory sequences. Arguably, the biggest successes have been achieved in the bacterium Escherichia coli, particularly in the context of the lac promoter (Vilar and Leibler, 2003; Kuhlman et al., 2007; Kinney et al., 2010; Garcia and Phillips, 2011; Brewster et al., 2014) and the O/O control region of the phage lysogen (Ackers et al., 1982; Shea and Ackers, 1985; Cui et al., 2013). But in both cases, this quantitative understanding has required decades of focused study. New approaches for dissecting cis-regulatory energetics, approaches that are both systematic and scalable, will be needed before a general quantitative understanding of cis-regulatory grammar can be developed.
Here we address this need by describing a systematic experimental/modeling strategy for dissecting the biophysical mechanisms of transcriptional regulation in living cells. Our strategy centers on the concept of an ‘allelic manifold’. Allelic manifolds generalize the classical genetics concept of allelic series to multiple dimensions. An allelic series is a set of sequence variants that affect the same phenotype (or phenotypes) but differ in their quantitative strength. Here we construct allelic manifolds by measuring, in multiple experimental contexts, the phenotypic strength of each variant in an allelic series. Each variant thus corresponds to a data point in a multi-dimensional ‘measurement space’. If the measurement space is of high enough dimension, and if one’s measurements are sufficiently precise, these data should collapse to a lower-dimension manifold that represents the inherent phenotypic dimensionality of the allelic series. These data can then be used to infer quantitative biophysical models that describe the shape of the allelic manifold, as well as the location of each allelic variant within that manifold. As we show here, such inference allows one to determine in vivo values for important biophysical quantities with remarkable precision.
We demonstrate this strategy on a regulatory paradigm in E. coli: activation of the RNA polymerase holoenzyme (RNAP) by the cAMP receptor protein (CRP, also called CAP). CRP activates transcription when bound to DNA at positions upstream of RNAP (Busby and Ebright, 1999), and the strength of these interactions is known to depend strongly on the precise nucleotide spacing between CRP and RNAP binding sites (Gaston et al., 1990; Ushida and Aiba, 1990). However, the Gibbs free energies of these interactions are still largely unknown. To our knowledge, only the CRP-RNAP interaction at the lac promoter has previously been quantitatively measured (Kuhlman et al., 2007; Kinney et al., 2010). By measuring and modeling allelic manifolds, we systematically determined the in vivo Gibbs free energy () of CRP-RNAP interactions that occur at a variety of different binding site spacings. These values were consistently measured to an estimated precision of ~ 0.1 kcal/mol. We also obtained values for in vivo CRP-DNA and RNAP-DNA interactions, again with similar estimated precision.
The Results section that follows is organized into three Parts, each of which describes a different use for allelic manifolds. Part 1 focuses on measuring TF-DNA interactions, Part 2 focuses on TF-TF interactions, and Part 3 shows how to distinguish different possible mechanisms of transcriptional activation. Each Part consists of three subsections: Strategy, Demonstration, and Aside. Strategy covers the theoretical basis for the proposed use of allelic manifolds. Demonstration describes how we applied this strategy to better understand regulation by CRP and RNAP. Aside describes related findings that are interesting but somewhat tangential.
Results
Part 1. Strategy: Measuring TF-DNA interactions
We begin by showing how allelic manifolds can be used to measure the in vivo strength of TF binding to a specific DNA binding site. This measurement is accomplished by using the TF of interest as a transcriptional repressor. We place the TF binding site directly downstream of the RNAP binding site in a bacterial promoter so that the TF, when bound to DNA, sterically occludes the binding of RNAP. We then measure the rate of transcription from a few dozen variant RNAP binding sites. Transcription from each variant site is assayed in both the presence and in the absence of the TF.
Figure 1A illustrates a thermodynamic model (Shea and Ackers, 1985; Bintu et al., 2005; Sherman and Cohen, 2012) for this type of simple repression. In this model, promoter DNA can be in one of three states: unbound, bound by the TF, or bound by RNAP. Each of these three states is assumed to occur with a frequency that is consistent with thermal equilibrium, that is with a probability proportional to its Boltzmann weight.
The energetics of protein-DNA binding determine the Boltzmann weight for each state. By convention we set the weight of the unbound state equal to 1. The weight of the TF-bound state is then given by where is the concentration of the TF and is the affinity constant in inverse molar units. Similarly, the weight of the RNAP-bound state is . In what follows we refer to and as the ‘binding factors’ of the TF-DNA and RNAP-DNA interactions, respectively. We note that these binding factors can also be written as and where is Boltzmann’s constant, is temperature, and and respectively denote the Gibbs free energy of binding for the TF and RNAP. Note that each Gibbs free energy accounts for the entropic cost of pulling each protein out of solution. In what follows, we report values in units of kcal/mol; note that 1 kcal/mol = at 37 °C.
The overall rate of transcription is computed by summing the amount of transcription produced by each state, weighting each state by the probability with which it occurs. In this case we assume the RNAP-bound state initiates at a rate of , and that the other states produce no transcripts. We also add a term, , to account for background transcription (e.g., from an unidentified promoter further upstream). The rate of transcription in the presence of the TF is thus given by
(1) |
In the absence of the TF (), the rate of transcription becomes
(2) |
Our goal is to measure the TF-DNA binding factor . To do this, we create a set of promoter sequences where the RNAP binding site is varied (thus generating an allelic series) but the TF binding site is kept fixed. We then measure transcription from these promoters in both the presence and absence of the TF, respectively denoting the resulting quantities by and (Figure 1B). Our rationale for doing this is that changing the RNAP binding site sequence should, according to our model, affect only the RNAP-DNA binding factor . All of our measurements are therefore expected to lie along a one-dimensional allelic manifold residing within the two-dimensional space of (, ) values. Moreover, this allelic manifold should follow the specific mathematical form implied by Equations 1 and 2 when is varied and the other parameters (, , ) are held fixed; see Figure 1C.
The geometry of this allelic manifold is nontrivial. Assuming and , there are five different regimes corresponding to different values of the RNAP binding factor . These regimes are listed in Figure 1D and derived in Appendix 4. In regime 1, is so small that both and are dominated by background transcription, that is is somewhat larger in regime 2, causing to be proportional to while remains dominated by background. In regime 3, both and are proportional to with . In regime 4, saturates at while remains proportional to . Regime five occurs when both and are saturated, that is .
Part 1. Demonstration: Measuring CRP-DNA binding
The placement of CRP immediately downstream of RNAP is known to repress transcription (Morita et al., 1988). We therefore reasoned that placing a DNA binding site for CRP downstream of RNAP would allow us to measure the binding factor of that site. Figure 2 illustrates measurements of the allelic manifold used to characterize the strength of CRP binding to the 22 bp site GAATGTGACCTAGATCACATTT. This site contains the well-known consensus site, which comprises two palindromic pentamers (underlined) separated by a 6 bp spacer (Gunasekera et al., 1992). We performed measurements using this CRP site centered at two different locations relative to the transcription start site (TSS): +0.5 bp and +4.5 bp. Note that the first transcribed base is, in this paper, assigned position 0 instead of the more conventional +1, and half-integer positions indicate centering between neighboring nucleotides. To avoid influencing CRP binding strength, the −10 region of the RNAP site was kept fixed in the promoters we assayed while the −35 region of the RNAP binding site was varied (Figure 2A). Promoter DNA sequences are shown in Appendix 1—figure 1.
We obtained and measurements for these constructs using a modified version of the colorimetric -galactosidase assay of Lederberg (1950) and Miller (1972); see Appendix 2 for details. Our measurements are largely consistent with an allelic manifold having the expected mathematical form (Figure 2B). Moreover, the measurements for promoters with CRP sites at two different positions (+0.5 bp and +4.5 bp) appear consistent with each other, although the measurements for +4.5 bp promoters appear to have lower values for overall. A small number of data points do deviate substantially from this manifold, but the presence of such outliers is not surprising from a biological perspective (see Discussion). Fortunately, outliers appear at a rate small enough for us to identify them by inspection.
We quantitatively modeled the allelic manifold in Figure 2B by fitting parameters to our measurements, where is the number of non-outlier promoters. The parameters were , , , and , , …, , where each is the RNAP binding factor of promoter . Nonlinear least squares optimization was used to infer values for these parameters. Uncertainties in , , and were quantified by repeating this procedure on bootstrap-resampled data points. See Appendix 3 for details.
These results yielded highly uncertain values for because none of our measurements appear to fall within regime 4 or 5 of the allelic manifold. A reasonably precise value for was obtained, but substantial scatter about our model predictions in regime 1 and 2 remain. This scatter likely reflects some variation in from promoter to promoter, variation that is to be expected since the source of background transcription is not known and the appearance of even very weak promoters could lead to such fluctuations.
These data do, however, determine a highly precise value for the strength of CRP-DNA binding: or, equivalently, kcal/mol. This allelic manifold approach is thus able to measure the strength of TF-DNA binding with a precision of ~ 0.1 kcal/mol. For comparison, the typical strength of a hydrogen bond in liquid water is −1.9 kcal/mol (Markovitch and Agmon, 2007).
We note that CRP forms approximately 38 hydrogen bonds with DNA when it binds to a consensus DNA site (Parkinson et al., 1996). Our result indicates that, in living cells, the enthalpy resulting from these and other interactions is almost exactly canceled by entropic factors. We also note that our in vivo value for is far smaller than expected from experiments in aqueous solution. The consensus CRP binding site has been measured in vitro to have an affinity constant of (Ebright et al., 1989). There are probably about 103 CRP dimers per cell (Schmidt et al., 2016), giving a concentration . Putting these numbers together gives a binding factor of . The nonspecific binding of CRP to genomic DNA and other molecules in the cell, and perhaps limited DNA accessibility as well, might be responsible for this ~ 105-fold disagreement with our in vivo measurements.
Part 1. Aside: Measuring changes in the concentration of active CRP
Varying cAMP concentrations in growth media changes the in vivo concentration of active CRP in the E. coli strain we assayed (JK10). Such variation is therefore expected to alter the CRP-DNA binding factor . We tested whether this was indeed the case by measuring multiple allelic manifolds, each using a different concentration of [cAMP] when measuring . These measurements were performed on promoters with CRP binding sites at +0.5 bp (Figure 3A). The resulting data are shown in Figure 3B. To these data, we fit allelic manifolds having variable values for , but fixed values for both and ( a.u. was inferred in the prior analysis for Figure 2B; a.u. was inferred in the subsequent analysis for Figure 5C).
This procedure allowed us to quantitatively measure changes in the RNAP binding factor , and thus changes in the in vivo concentration of active CRP. Our results, shown in Figure 3C, suggest a nontrivial power law relationship between and [cAMP]. To quantify this relationship, we performed least squares regression ( against ) using data for the four largest cAMP concentrations; measurements of for the three other cAMP concentrations have large asymmetric uncertainties and were therefore excluded. We found that , with error bars representing a 95% confidence interval. We emphasize, however that our data do not rule out a more complex relationship between [cAMP] and .
There are multiple potential explanations for this deviation from proportionality. One possibility is cooperative binding of cAMP to the two binding sites within each CRP dimer. Such cooperativity could, for instance, result from allosteric effects like those described in Einav et al., 2018. Alternatively, this power law behavior might reflect unknown aspects of how cAMP is imported and exported from E. coli cells. It is worth comparing and contrasting this result to those reported in Kuhlman et al. (2007). JK10, the E. coli strain used in our experiments, is derived from strain TK310, which was developed in Kuhlman et al. (2007). In that work, the authors concluded that , whereas our data leads us to reject this hypothesis. This illustrates one way in which using allelic manifolds to measure how in vivo TF concentrations vary with growth conditions can be useful.
Part 2. Strategy: Measuring TF-RNAP interactions
Next we discuss how to measure an activating interaction between a DNA-bound TF and DNA-bound RNAP. A common mechanism of transcriptional activation is ‘stabilization’ (also called ‘recruitment’; see Ptashne, 2003). This occurs when a DNA-bound TF stabilizes the RNAP-DNA closed complex. Stabilization effectively increases the RNAP-DNA binding affinity , and thus the binding factor . It does not affect , the rate of transcript initiation from RNAP-DNA closed complexes.
A thermodynamic model for activation by stabilization is illustrated in Figure 4A. Here promoter DNA can be in four states: unbound, TF-bound, RNAP-bound, or doubly bound. In the doubly bound state, a ‘cooperativity factor’ contributes to the Boltzmann weight. This cooperativity factor is related to the TF-RNAP Gibbs free energy of interaction, , via . Activation occurs when (i.e., ). The resulting activated transcription rate is given by
(3) |
This can be rewritten as
(4) |
where
(5) |
is a renormalized cooperativity that accounts for the strength of TF-DNA binding. As before, is given by Equation 2. Note that and that when and .
As before, we measure both and for an allelic series of RNAP binding sites (Figure 4B). These measurements will, according to our model, lie along an allelic manifold resembling the one shown in Figure 4C. This allelic manifold exhibits five distinct regimes (when ), which are listed in Figure 4D.
Part 2. Demonstration: Measuring class I CRP-RNAP interactions
CRP activates transcription at the lac promoter and at other promoters by binding to a 22 bp site centered at −61.5 bp relative to the TSS. This is an example of class I activation, which is mediated by an interaction between CRP and the C-terminal domain of one of the two RNAP subunits (the CTDs) (Busby and Ebright, 1999). In vitro experiments have shown this class I CRP-RNAP interaction to activate transcription by stabilizing the RNAP-DNA closed complex.
We measured and for 47 variants of the lac* promoter (see Appendix 1—figure 1 for sequences). These promoters have the same CRP binding site assayed for Figure 2, but positioned at −61.5 bp relative to the TSS (Figure 5A). They differ from one another in the −10 or −35 regions of their RNAP binding sites. Figure 5B shows the resulting measurements. With the exception of 3 outlier points, these measurements appear consistent with stabilizing activation via a Gibbs free energy of kcal/mol, corresponding to a cooperativity of . We note that, with determined in Figure 2B, to 4% accuracy.
This observed cooperativity is substantially stronger than suggested by previous work. Early in vivo experiments suggested a much lower cooperativity value, for example 50-fold (Beckwith et al., 1972), 20-fold (Ushida and Aiba, 1990), or even 10-fold (Gaston et al., 1990). These previous studies, however, only measured the ratio for a specific choice of RNAP binding site. This ratio is (by Equation 4) always less than and the differences between these quantities can be substantial. However, even studies that have used explicit biophysical modeling have determined lower cooperativity values: Kuhlman et al. (2007) reported a cooperativity of ( kcal/mol), while Kinney et al. (2010) reported ( kcal/mol). Both of these studies, however, relied on the inference of complex biophysical models with many parameters. The allelic manifold in Figure 4, by contrast, is characterized by only three parameters (, , ), all of which can be approximately determined by visual inspection.
To test the generality of this approach, we measured allelic manifolds for 11 other potential class I promoter architectures. At every one of these positions we clearly observed the collapse of data to a 1D allelic manifold of the expected shape (Figure 5C). We then modeled these data using values of and that depend on CRP binding site location, as well as a single overall value for . The resulting values for (and equivalently ) are shown in Figure 5D and reported in Table 1. As first shown by Gaston et al. (1990) and Ushida and Aiba (1990), depends strongly on the spacing between the CRP and RNAP binding sites. In particular, exhibits a strong ~ 10.5 bp periodicity reflecting the helical twist of DNA. However, as with the measurement in Figure 5B, the values we measure are far larger than the ratios previously reported by Gaston et al. (1990) and Ushida and Aiba (1990); see Table 1. We also find a.u. The single-cell observations of So et al. (2011) suggest that this corresponds to transcripts per minute. By pure coincidence, the ‘arbitrary unit’ (a.u.) units we use in this paper correspond very closely to ‘transcripts per minute’.
Table 1. Summary of results for class I activation by CRP.
Position (bp) | Outliers | (kcal/mol) | (Gaston) | (Ushida) | ||
---|---|---|---|---|---|---|
−60.5 | 21 | 0 | 3.85 | - | ||
−61.5 | 44 | 3 | 9.05 | 20.6 | ||
−62.5 | 23 | 0 | 4.22 | - | ||
−63.5 | 20 | 1 | - | - | ||
−64.5 | 17 | 0 | - | - | ||
−65.5 | 17 | 0 | - | - | ||
−66.5 | 19 | 1 | 0.78 | 0.84 | ||
−71.5 | 35 | 1 | 2.50 | 16.4 | ||
−72.5 | 20 | 0 | 3.49 | - | ||
−76.5 | 16 | 0 | 0.54 | - | ||
−81.5 | 32 | 0 | - | - | ||
−82.5 | 20 | 0 | - | 6.99 |
Part 2. Aside: Difficulties predicting binding affinity from DNA sequence
The measurement and modeling of allelic manifolds sidesteps the need to parametrically model how protein-DNA binding affinity depends on DNA sequence. In modeling the allelic manifolds in Figure 5C, we obtained values for the RNAP binding factor, , for each variant RNAP binding site from the position of the corresponding data point along the length of the manifold.
RNAP has a very well established sequence motif (McClure et al., 1983). Indeed, its DNA binding requirements were among the first characterized for any DNA-binding protein (Pribnow, 1975). More recently, a high-resolution model for RNAP-DNA binding energy was determined using data from a massively parallel reporter assay called Sort-Seq (Kinney et al., 2010). This position-specific affinity matrix (PSAM) assumes that the nucleotide at each position contributes additively to the overall binding energy (Figure 6A). This model is consistent with previously described RNAP binding motifs but, unlike those motifs, it can predict binding energy in physically meaningful energy units (i.e., kcal/mol). In what follows we denote these binding energies as , because they describe differences in the Gibbs free energy of binding between two DNA sites.
There is good reason to believe this PSAM to be the most accurate current model of RNAP-DNA binding. However, subsequent work has suggested that the predictions of this model might still have substantial inaccuracies (Brewster et al., 2012). To investigate this possibility, we compared our measured values for the Gibbs free energy of RNAP-DNA binding () to binding energies () predicted using the PSAM from Kinney et al. (2010). These values are plotted against one another in Figure 6B. Although there is a strong correlation between the predictions of the model and our measurements, deviations of 1 kcal/mol or larger (corresponding to variations in of 5-fold or greater) are not uncommon. Model predictions also systematically deviate from the diagonal, suggesting inaccuracy in the overall scale of the PSAM.
This finding is sobering: even for one of the best understood DNA-binding proteins in biology, our best sequence-based predictions of in vivo protein-DNA binding affinity are still quite crude. When used in conjunction with thermodynamic models, as in Kinney et al. (2010), the inaccuracies of these models can have major effects on predicted transcription rates. The measurement and modeling of allelic manifolds sidesteps the need to parametrically model such binding energies, enabling the direct inference of Gibbs free energy values for each assayed RNAP binding site.
Part 3. Strategy: Distinguishing mechanisms of transcriptional activation
E. coli TFs can regulate multiple different steps in the transcript initiation pathway (Lee et al., 2012; Browning and Busby, 2016). For example, instead of stabilizing RNAP binding to DNA, TFs can activate transcription by increasing the rate at which DNA-bound RNAP initiates transcription (Roy et al., 1998), a process we refer to as ‘acceleration’. CRP, in particular, has previously been reported to activate transcription in part by acceleration when positioned appropriately with respect to RNAP (Niu et al., 1996; Rhodius et al., 1997).
We investigated whether allelic manifolds might be used to distinguish activation by acceleration from activation by stabilization. First we generalized the thermodynamic model in Figure 4A to accommodate both -fold stabilization and -fold acceleration (Figure 7A). This is accomplished by using the same set of states and Boltzmann weights as in the model for stabilization, but assigning a transcription rate (rather than just ) to the TF-RNAP-DNA ternary complex. The resulting activated rate of transcription is given by
(6) |
This simplifies to
(7) |
where is the same as in Equation 5 and
(8) |
is a renormalized version of the acceleration rate . The resulting allelic manifold is illustrated in Figure 7C. Like the allelic manifold for stabilization, this manifold has up to five distinct regimes corresponding to different values of (Figure 7D). Unlike the stabilization manifold however, in the strong RNAP binding regime (regime 5); rather, while .
Part 3. Demonstration: Mechanisms of class I activation by CRP
We asked whether class I activation by CRP has an acceleration component. Previous in vitro work had suggested that the answer is ‘no’ (Malan et al., 1984; Busby and Ebright, 1999), but our allelic manifold approach allows us to address this question in vivo. We proceeded by assaying promoters containing variant alleles of the consensus RNAP binding site (Figure 8A). Note that the consensus RNAP site is 1 bp shorter than the lac* RNAP site (Appendix 1—figure 1, panel C versus panel B). We therefore positioned the CRP binding site at −60.5 bp in order to realize the same spacing between CRP and the −35 element of the RNAP binding site that was realized in −61.5 bp non-consensus promoters.
The resulting data (Figure 8B) are seen to largely fall along the previously measured all-stabilization allelic manifold in Figure 5B. In particular, many of these data points lie at the intersection of this manifold with the diagonal. We thus find that for CRP at −61.5 bp. To further quantify possible values, we fit the acceleration model in Figure 7 to each dataset shown in Figure 5B, assuming a fixed value of a.u. The resulting inferred values for , shown in Figure 8C, indicate little if any deviation from . Our high-precision in vivo results therefore substantiate the previous in vitro results of Malan et al. (1984) regarding the mechanism of class I activation.
Part 3. Aside: Surprises in class II regulation by CRP
Many E. coli TFs participate in what is referred to as class II activation (Browning and Busby, 2016). This type of activation occurs when the TF binds to a site that overlaps the −35 element (often completely replacing it) and interacts directly with the main body of RNAP. CRP is known to participate in class II activation at many promoters (Keseler et al., 2011; Salgado et al., 2013), including the galP1 promoter, where it binds to a site centered at position −41.5 bp (Adhya, 1996). In vitro studies have shown CRP to activate transcription at −41.5 bp relative to the TSS through a combination of stabilization and acceleration (Niu et al., 1996; Rhodius et al., 1997).
We sought to reproduce this finding in vivo by measuring allelic manifolds. We therefore placed a consensus CRP site at −41.5 bp, replacing much of the −35 element in the process, and partially mutated the −10 element of the RNAP binding site (Figure 9A). Surprisingly, we observed that the resulting allelic manifold saturates at the same value shared by all class I promoters. Thus, CRP appears to activate transcription in vivo solely through stabilization, and not at all through acceleration, when located at −41.5 bp relative to the TSS (Figure 9B).
The genome-wide distribution of CRP binding sites suggests that CRP also participates in class II activation when centered at −40.5 bp (Keseler et al., 2011; Salgado et al., 2013). When assaying this promoter architecture, however, we obtained a 2D scatter of points that did not collapse to any discernible 1D allelic manifold (Figure 9D). Some of these promoters exhibit activation, some exhibit repression, and some exhibit no regulation by CRP.
These observations complicate the current understanding of class II regulation by CRP. Our in vivo measurements of CRP at −41.5 bp call into question the mechanism of activation previously discerned using in vitro techniques. The scatter observed when CRP is positioned at −40.5 bp suggests that, at this position, the −10 region of the RNAP binding site influences the values of at least two relevant biophysical parameters (not just , as our model predicts). A potential explanation for both observations is that, because CRP and RNAP are so intimately positioned at class II promoters, even minor changes in their relative orientation caused by differences between in vivo and in vitro conditions or by changes in RNAP site sequence could have a major effect on CRP-RNAP interactions. Such sensitivity would not be expected to occur in class I activation, due to the flexibility with which the RNAP CTDs are tethered to the core complex of RNAP.
Discussion
We have shown how the measurement and quantitative modeling of allelic manifolds can be used to dissect cis-regulatory biophysics in living cells. This approach was demonstrated in E. coli in the context of transcriptional regulation by two well-characterized TFs: RNAP and CRP. Here we summarize our primary findings. We then address some caveats and limitations of the work reported here. Finally, we elaborate on how future studies might be able to scale up this approach using massively parallel reporter assays (MPRAs), including for studies in eukaryotic systems.
Summary
In each of our experiments, we quantitatively measured transcription from an allelic series of variant RNAP binding sites, each site embedded in a fixed promoter architecture. Two expression measurements were made for each variant promoter: was measured in the presence of the active form of CRP, while was measured in the absence of active CRP. This yielded a data point, , in a two-dimensional measurement space. We had expected the data points thus obtained for each allelic series to collapse to a 1D curve (the allelic manifold), with different positions along this manifold corresponding to different values of RNAP-DNA binding affinity. Such collapse was indeed observed in all but one of the promoter architectures we studied. By fitting the parameters of quantitative biophysical models to these data, we obtained in vivo values for the Gibbs free energy () of a variety of TF-DNA and TF-TF interactions.
In Part 1, we showed how measuring allelic manifolds for promoters in which a DNA-bound TF occludes RNAP can allow one to precisely measure the of TF-DNA binding. We demonstrated this strategy on promoters where CRP occludes RNAP, thereby obtaining the for a CRP binding site that was used in subsequent experiments. As an aside, we demonstrated how performing such measurements in different concentrations of the small molecule cAMP allowed us to quantitatively measure in vivo changes in active CRP concentration.
In Part 2, we showed how allelic manifolds can be used to measure the of TF-RNAP interactions. We used this strategy to measure the stabilizing interactions by which CRP up-regulates transcription at a variety of class I promoter architectures. Our strategy consistently yielded values with an estimated precision of kcal/mol. As an aside, we showed how values for RNAP-DNA binding could also be obtained from these data. Notably, these measurements for RNAP-DNA binding were seen to deviate substantially from sequence-based predictions using an established position-specific affinity matrix (PSAM) for RNAP. This highlights just how difficult it can be to accurately predict TF-DNA binding affinity from DNA sequence.
In Part 3, we showed how allelic manifolds can allow one to distinguish between two potential mechanisms of transcriptional activation: ‘stabilization’ (a.k.a. ‘recruitment’) and ‘acceleration’. Applying this approach to the data from Part 2, we confirmed (as expected) that class I activation by CRP does indeed occur through stabilization and not acceleration. As an aside, we pursued this approach at two class II promoters. In contrast to prior in vitro studies (Niu et al., 1996; Rhodius et al., 1997), no acceleration was observed when CRP was positioned at −41.5 bp relative to the TSS. Even more unexpectedly, no 1D allelic manifold was observed at all when CRP was positioned at −40.5 bp. This last finding indicates that the variant RNAP binding sites we assayed control at least one functionally important biophysical quantity in addition to RNAP-DNA binding affinity.
Caveats and limitations
An important caveat is that our measurements assume that the true transcription rates (of which we obtain only noisy measurements) exactly fall along a 1D allelic manifold of the hypothesized mathematical form. These assumptions are well-motivated by the data collapse that we observed for all except one promoter architecture. But for some promoter architectures, there were a small number of ‘outlier’ data points that we judged (by eye) to deviate substantially from the inferred allelic manifold. The presence of a few outliers makes sense biologically: the random mutations we introduced into variant RNAP binding sites will, with some nonzero probability, either shift the position of the RNAP site or create a new binding site for some other TF. However, even for promoters that exhibit clear clustering of 2D data around a 1D curve, the deviations of individual non-outlier data points from our inferred allelic manifold were often substantially larger than the experimental noise that we estimated from replicates. It may be that the biological cause of outliers is not qualitatively different from what causes these smaller but still detectable deviations from our assumed model.
The low-throughput experimental approach we pursued here also has important limitations. Each of the 448 variant promoters for which we report data was individually catalogued, sequenced, and assayed for both and in at least three replicate experiments. We opted to use a low-throughput colorimetric assay of -galactosidase activity (Lederberg, 1950; Miller, 1972) because this approach is well established in E. coli to produce a quantitative measure of transcription with high precision and high dynamic range. Such assays have also been used by other groups to develop sophisticated biophysical models of transcriptional regulation (Kuhlman et al., 2007; Cui et al., 2013). However, this low-throughput approach has limited utility because it cannot be readily scaled up.
Our reliance on cAMP as a small molecule effector of CRP presents a second limitation. In our experiments, we controlled the in vivo activity of CRP by growing a specially designed strain of E. coli in either the presence (for ) or absence () of cAMP. This mirrors the strategy used by Kuhlman et al. (2007), and the validity of this approach is attested to by the calibration data shown in Appendix 2—figure 1. However, controlling in vivo TF activity using small molecules has many limitations. Most TFs cannot be quantitatively controlled with small molecules, and those that can often require special host strains (e.g., see Kuhlman et al., 2007). Moreover, varying the in vivo concentration of a TF can affect cellular physiology in ways that can confound quantitative measurements.
Outlook
MPRAs performed on array-synthesized promoter libraries should be able to overcome both of these experimental limitations. Current MPRA technology is able to quantitatively measure gene expression for 104 transcriptional regulatory sequences in parallel. We estimate that this would enable the simultaneous measurement of ~ 102 highly resolved allelic manifolds, each manifold representing a different promoter architecture. Moreover, by using array-synthesized promoters in conjunction with MPRAs, one can measure and by systematically altering the DNA sequence of TF binding sites, rather than relying on small molecule effectors of each TF. This capability would, among other things, enable biophysical studies of promoters that have multiple binding sites for the same TF; in such cases it might make sense to use measurement spaces having more than two dimensions.
Will allelic manifolds be useful for understanding transcriptional regulation in eukaryotes? Both Sort-Seq MPRAs (Sharon et al., 2012; Weingarten-Gabbay et al., 2017) and RNA-Seq MPRAs (Melnikov et al., 2012; Kwasnieski et al., 2012; Patwardhan et al., 2012) are well established in eukaryotes so, on a technical level, experiments analogous to those described here should be feasible. The bigger question, we believe, is whether the results of such experiments would be interpretable. Eukaryotic transcriptional regulation is far more complex than transcriptional regulation in bacteria. Still, we believe that pursuing the measurement and modeling of allelic manifolds in this context is worthwhile. Despite the underlying complexities, simple ‘effective’ biophysical models might work surprisingly well. Similar approaches might also be useful for studying other eukaryotic regulatory processes that are compatible with MPRAs, such as alternative splicing (Wong et al., 2018).
Based on these results, we advocate a very different approach to dissecting cis-regulatory grammar than has been pursued by other groups. Rather than attempting to identify a single quantitative model that can explain regulation by many different arrangements of TF binding sites (Gertz et al., 2009; Sharon et al., 2012; Mogno et al., 2013; Smith et al., 2013; Levo and Segal, 2014; White et al., 2016), we suggest focused studies of the biophysical interactions that result from specific TF binding site arrangements. The measurement and modeling of allelic manifolds provides a systematic and stereotyped way of doing this. By coupling this approach with MPRAs, it should be possible to perform such studies on hundreds of systematically varied regulatory sequence architectures in parallel. General rules governing cis-regulatory grammar might then be identified empirically. We suspect that this bottom-up strategy to studying cis-regulatory grammar is likely to reveal regulatory mechanisms that would be hard to anticipate in top-down studies.
Materials and methods
Key resources table.
Reagent type (species) or resource |
Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Genetic reagent (E. coli) |
JK10 | this paper | none | genotype: ∆cyaA ∆cpdA
∆lacY ∆lacZ ∆dksA |
Recombinant DNA reagent |
pJK47.419 |
this paper |
none |
cloning vector with BsmBI cut sites, ccdB cassette, lacZ reporter gene, kanamycin resistance, pSC101 origin |
Recombinant DNA reagent |
pJK48 and variants |
this paper | none | reporter plasmids cloned from pJK47.419 |
Chemical compound |
cAMP | Sigma-Aldrich | A9501-1G | Adenosine 3’,5’-cyclic monophosphate, 1 gram |
Chemical compound |
IPTG | Sigma-Aldrich | I5502-1G | Isopropyl β-D-1- thiogalactopyranoside, 1 gram |
Chemical compound |
ONPG | Sigma-Aldrich | N1127-5G | 2-Nitrophenyl β-D-galactopyranoside, 5 gram |
Commercial assay or kit |
PureLink Genomic DNA Mini Kit |
ThermoFisher | K182001 | none |
Commercial assay or kit |
Nextera XT DNA Library Preparation Kit |
Illumina |
FC-131–1024 |
24 samples |
Other | RDM | Teknova | M2105 | growth media: MOPS EZ Rich Defined Medium Kit, 5 liter |
Other | PopCulture Reagent |
MilliporeSigma | 71092–4 | 75 milliliters |
Other | Breathe-Easier film | USA Scientific | 9123–6100 | sterile, 100 per box |
Other | Epoch 2 Microplate Spectrophotometer |
BioTek |
EPOCH2C |
none |
Software | analysis scripts | this paper | none | Available at https://github.com/jbkinney/17_inducibility
(copy archived at https://github.com/elifesciences-publications/17_inducibility) |
Appendix 1 describes the media, strains, plasmids, and promoters assayed in this work. Appendix 2 describes the colorimetric -galactosidase activity assay, adapted from Lederberg (1950) and Miller (1972), that was used to measure expression levels. Appendix 3 provides details about how quantitative models were fit to these measurements, as well as how uncertainties in estimated parameters were computed. Supplementary file 1 is an Excel spreadsheet containing the DNA sequences of all assayed promoters, all and measurements used in this work, and all of the parameter values fit to these data, both with and without bootstrap resampling.
Acknowledgments
We thank Stirling Churchman, Barak Cohen, David McCandlish, Bryce Nickels, and Saurabh Sinha for helpful discussions. We also thank Naama Barkai, Ulrich Gerland, Richard Neher, and one anonymous referee for reviewing this manuscript and providing helpful feedback. This work was supported by a CSHL/Northwell Health Alliance grant to JBK and by NIH Cancer Center Support Grant 5P30CA045508.
Appendix 1
Media, strains, plasmids, and promoters
Expression measurements were performed on cells grown in rich defined media (RDM; purchased from Teknova) (Neidhardt et al., 1974) supplemented with 10 mM NaHCO, 1 mM IPTG (Sigma), and 0.2% glucose. We refer to this media as RDM’. RDM’ was further supplemented with 50 µg/ml kanamycin (Sigma) when growing cells, as well as 250 µM cAMP (Sigma) when measuring .
Expression measurements were performed in E. coli strain JK10, which has genotype ΔcyaA ΔcpdA ΔlacY ΔlacZ ΔdksA. JK10 is derived from strain TK310 (Kuhlman et al., 2007), which is ΔcyaA ΔcpdA ΔlacY. The ΔcyaA ΔcpdA mutations prevent TK310 from synthesizing or degrading cAMP, thus allowing in vivo cAMP concentrations to be quantitatively controlled by adding cAMP to the growth media. Into TK310 we introduced the ΔlacZ mutation, yielding strain DJ33; this mutation enables the use of -galactosidase activity assays for measuring plasmid-based lacZ expression. In our initial experiments, we found that the growth rate of DJ33 in RDM’ varied strongly with the amount of cAMP added to the media. Fortunately, we isolated a spontaneous knock-out mutation in dksA (thus yielding JK10), which caused the growth rate (~ 30 min doubling time) in RDM’ to be independent of cAMP concentrations below ~500 µM. We note that JK10 will not grow in minimal media in the absence of cAMP. The TK310, DJ33, and JK10 genotypes were confirmed by whole genome sequencing using the PureLink Genomic DNA Mini Kit (ThermoFisher) for extracting genomic DNA from cultured cells and the Nextera XT DNA Library Preparation Kit (Illumina) for preparing whole-genome sequencing libraries.
Expression of the lacZ gene was driven from variants of a plasmid we call pJK48. These reporter constructs were cloned as follows. We started with the vector pJK14 from Kinney et al. (2010). pJK14 contains a pSC101 origin of replication (~ 5 copies per cell; Thompson et al., 2018), a kanamycin resistance gene, and a ccdB cloning cassette positioned immediately upstream of a gfpmut2 reporter gene and flanked by outward-facing BsmBI restriction sites. First, the gfpmut2 gene in this vector was replaced with lacZ, yielding pJK47. Next, the ribosome binding site in the 5’ UTR of lacZ was weakened, yielding pJK47.419; this weakening prevents lacZ expression from substantially slowing cell growth in RDM’. pJK47.419 was propagated in DB3.1 E. coli (Invitrogen), which is resistant to the CcdB toxin. The promoters we assayed were variants of what we call the ‘lac*’ promoter. The lac* promoter is similar to the endogenous lac promoter of E. coli MG1655 except for (i) it contains a CRP binding site with a consensus right pentamer and (ii) it contains mutations that were introduced in an effort to remove previously reported cryptic promoters (Reznikoff, 1992). Promoter-containing insertion cassettes were created through overlap-extension PCR and flanked by outward-facing BsaI restriction sites. All primers were ordered from Integrated DNA Technologies. Note that some of the primers used to create these inserts were synthesized using pre-mixed phosphoramidites at specified positions; this is how a 24% mutation rate in the −10 or −35 regions of the RNAP binding site was achieved. The resulting promoter sequences are illustrated in Appendix 1—figure 1. To clone variants of pJK48, we separately digested the pJK47.419 vector with BsmBI (NEB) and the appropriate insert with BsaI (NEB). Digests were then cleaned up (Qiagen PCR purification kit) and ligated together in a 1:1 molar ratio for 1 hr using T4 DNA ligase (Invitrogen). After 90 min dialysis, plasmids were transformed into electrocompetent JK10 cells. Individual clones were plated on LB supplemented with kanamycin (50 µg/ml). After initial cloning and plating, each colony was re-streaked, grown in LB+kan, and stored as a catalogued glycerol stock. The promoter region of each clone was sequenced in both directions. Only plasmids with validated promoter sequences were used for the measurements presented in this paper. The promoter sequences of all 448 plasmids used in this study, as well as their measured and values, are provided at https://github.com/jbkinney/17_inducibility (copy archived at https://github.com/elifesciences-publications/17_inducibility).
Appendix 2
Miller assays and the calibration of expression measurements
We obtained and measurements for each promoter as follows. First, the corresponding E. coli clone was streaked out on LB+kan agar and grown overnight. A colony was then picked and used to inoculate a 1.5 ml overnight LB+kan liquid culture. Either 8 µl, 6 µl, or 4 µl of the overnight culture were then diluted into 200 µl RDM’+kan. 25 µl of each dilution was then added to 175 µl RDM’+kan in a 96-well optical bottom plate and supplemented with either 0 µM cAMP (for ), 250 µM cAMP (for ), or another cAMP concentration (for some measurements in Figure 3). The plate was then covered with Breathe-Easier film (USA Scientific) and cells were cultured for hr at 37 °C, shaking at 900 RPM in a microplate shaker. During this time, 5.5 ml of lysis buffer was freshly prepared using 1.5 ml RDM’, 4.0 ml PopCulture reagent (Millipore), 114 µl of 35 mg/ml chloramphenicol (Sigma), and 44 µl of 40 U/µl rLysozyme (Sigma).
Microplate film was removed and cell density (quantified by ) was measured using an Epoch 2 Microplate Spectrophotometer (BioTek). Cells were then lysed by adding 25 µl lysis buffer to each microplate well, incubating the microplate at room temperature for 10 min without shaking, then cooling the microplate at 4 °C for a minimum of 15 min. In each well of a 96-well optical bottom plate, 50 µl of lysate was then added to 50 µl of pre-chilled Z-buffer (Miller, 1972) containing 1 mg/ml ONPG (Sigma). Samples were sealed with optical film and both and were periodically measured in the plate reader over an extended period of time (every 1.5 min for 1 hr or every 15 min for 10 hr, depending on the level of expression expected).
The raw expression levels were quantified from these absorbance data using the formula
(9) |
where = 50 is the volume of lysate in µl added to the ONPG reaction, is the change in time from the beginning of the measurement, and indicates a change in absorbance at nm over this time interval. Only data from wells with were analyzed. Note that the term in Equation 9 is not multiplied by 1.75 as it is in Miller (1972). This is because our measurements are used to compensate for condensation on the microplate film, not cellular debris as in Miller (1972); our lysis procedure produces no detectable cellular debris. In practice, Equation 9 was not evaluated using individual measurements, but was computed from the slope of a line fit to all of the non-saturated absorbance measurements. Raw , , and values, as well as our analysis scripts, are available at https://github.com/jbkinney/17_inducibility (copy archived at https://github.com/elifesciences-publications/17_inducibility). Median values from at least three independent Miller measurements (and often more) were used to define each measurement shown in the main figures.
Because we controlled the in vivo activity of CRP by supplementing media with or without cAMP, we tested whether CRP-independent promoters produce measurements that vary between these growth conditions. Specifically, we measured (in 0 µM cAMP) and (in 250 µM cAMP) for 39 promoters in which the CRP binding site was replaced with a ‘null’ site (see Appendix 1—figures 1B and C). These measurements are plotted in Appendix 2—figure 1, and show a slight bias. To correct for this bias, we use an unadjusted together with an adjusted throughout the main text. Note that was used for all nonzero cAMP concentrations, including those in Figure 3B that differ from 250 µM. Some upward bias is therefore possible in these measurements, but we do not expect this to greatly affect our conclusions.
Appendix 3
Parameter inference
Allelic manifold parameters were fit to measured and values as follows. First, outlier data points were called by eye and excluded from the parameter fitting procedure. We denote the remaining measurements using and , where indexes the non-outlier data points. Corresponding model predictions and , where denotes model parameters, were then fit to these data using nonlinear least squares optimization. Specifically, we inferred parameters where the loss function is given by
(10) |
These optimal parameter values were used to generate the best-estimate allelic manifolds, which are plotted in black in the main figures. Uncertainties in were estimated by performing the same inference procedure on bootstrap-resampled data. For each variable , we report
(11) |
where , , and respectively denote the median, 84th percentile, and 16th percentile of values obtained from bootstrap resampling. In the case of , we also report
(12) |
where 1 kcal/mol = at 37 °C. We now describe each specific inference procedure in more detail.
Inference for Figure 2B
We inferred , with model predictions given by
(13) |
Parameters were fit to the non-outlier measurements made for promoters with +0.5 bp or +4.5 bp architecture. We found that and a.u., while values remained highly uncertain.
Inference for Figure 3B
We performed a separate inference procedure for each of the seven cAMP concentrations , indicated in µM units. Specifically, we inferred where is the number of promoters for which was measured using cAMP concentration . Model predictions were given by
(14) |
where a.u. is the median saturated transcription rate from Figure 5C, and a.u. is the median background transcription rate from Figure 2B. Note that many of the measurements were used in the inference procedures for multiple values of , whereas each measurement was used in only one such inference procedure.
Inference for Figure 5B
Using data from both the −10 and −35 allelic series for the −61.5 bp promoter architecture, we inferred . Model predictions were given by
(15) |
For each inferred , a value for was computed using , where is the median CRP binding factor inferred for Figure 2B.
Inference for Figure 5C
In a single fitting procedure, we inferred using
(16) |
where each represents the position of the CRP binding site (in bp relative to the TSS) for promoter . Note that a single value for was inferred for all promoter architectures, while both and varied with CRP position . The corresponding values of plotted in Figure 5D and listed in the Table 1 were computed using where is the median CRP binding factor inferred for Figure 2B. Among other results, we find that a.u.
Inference for Figure 8C
For each spacing , we separately inferred using
(17) |
where a.u. is the median saturated transcription rate inferred for Figure 5C. We then computed and , using the median CRP binding factor inferred for Figure 2B.
Appendix 4
Derivation of allelic manifold regimes
Each transcription rate modeled in this work is a sigmoidal function of the unitless RNAP-DNA binding factor . As such, a log-log plot of transcription as a function of reveals a sigmoidal curve having three distinct regimes. The 'minimal' regime of this induction curve comprises values of that are sufficiently small for to be well-approximated by its smallest value ( in all cases). The 'maximal' regime occurs when is so large that is well-approximated by its largest value (either or ). Between these maximal and minimal regimes lies a 'linear' regime in which is approximately proportional to .
For unregulated transcription, which in this paper is denoted , these three regimes are given by
(18) |
see Appendix 4—figure 1A. For transcription that is repressed by occlusion (with ), which we denote here by , these three regimes are shifted (relative to ) to larger values of by a factor of approximately . As a result,
(19) |
see Appendix 4—figure 1B. By contrast, for transcription that is activated by stabilization, denoted here by , these three regimes shift (relative to ) to lower values of by a factor of , giving
(20) |
see Appendix 4—figure 1C. For transcription that is activated partially by acceleration and partially by stabilization, here denoted by , two parameters govern the shape of the induction curve. As a result, the boundary between the minimal and linear regimes are shifted (relative to ) to lower values of by a factor of , while the boundary between the linear regime and the maximal regime is shifted down by a factor of only . As a result,
(21) |
see Appendix 4—figure 1D.
Each allelic manifold described in the main text has five distinct regimes. These arise from overlaps between the three regimes of and the three regimes of . Specifically, the five regimes of the allelic manifold for repression by occlusion, which are listed in Figure 1D, arise from the overlaps between the three regimes for and the three regimes for . These overlaps are indicated in Appendix 4—figure 1E. Similarly, the five regimes of the allelic manifold for activation by stabilization (Figure 4D) arise from the overlaps between the regimes of and , illustrated in Appendix 4—figure 1F, while the regimes of the manifold for activation by acceleration (Figure 7D) arise from overlaps between the regimes of and , illustrated in Appendix 4—figure 1G.
Funding Statement
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Contributor Information
Justin B Kinney, Email: jkinney@cshl.edu.
Richard A Neher, University of Basel, Switzerland.
Naama Barkai, Weizmann Institute of Science, Israel.
Funding Information
This paper was supported by the following grant:
National Cancer Institute 5P30CA045508 to Justin B Kinney.
Additional information
Competing interests
No competing interests declared.
Author contributions
Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing-review and editing.
Data curation, Validation, Investigation, Methodology, Writing-review and editing.
Data curation, Validation, Investigation, Methodology.
Conceptualization, Investigation, Methodology.
Supervision, Funding acquisition, Writing—review and editing.
Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing.
Additional files
Data availability
All data used to make the Figures is available in Supplementary file 1. The PSAM for RNAP, previously published by Kinney et al. (2010), is also provided in Supplementary file 1 (with permission). Raw data, processed data, and analysis scripts are also available at https://github.com/jbkinney/17_inducibility (copy archived at https://github.com/elifesciences-publications/17_inducibility). No datasets have been deposited in public databases as part of this work.
References
- Ackers GK, Johnson AD, Shea MA. Quantitative model for gene regulation by lambda phage repressor. PNAS. 1982;79:1129–1133. doi: 10.1073/pnas.79.4.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adhya S. Regulation of Gene Expression in Esherichia Coli. Switzerland: Springer Nature; 1996. The lac and gal operons today; pp. 181–200. [DOI] [Google Scholar]
- Beckwith J, Grodzicker T, Arditti R. Evidence for two sites in the lac promoter region. Journal of Molecular Biology. 1972;69:155–160. doi: 10.1016/0022-2836(72)90031-9. [DOI] [PubMed] [Google Scholar]
- Belliveau NM, Barnes SL, Ireland WT, Jones DL, Sweredoski MJ, Moradian A, Hess S, Kinney JB, Phillips R. Systematic approach for dissecting the molecular mechanisms of transcriptional regulation in bacteria. PNAS. 2018;115:E4796–E4805. doi: 10.1073/pnas.1722055115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bintu L, Buchler NE, Garcia HG, Gerland U, Hwa T, Kondev J, Phillips R. Transcriptional regulation by the numbers: models. Current Opinion in Genetics & Development. 2005;15:116–124. doi: 10.1016/j.gde.2005.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brewster RC, Jones DL, Phillips R. Tuning promoter strength through RNA polymerase binding site design in Escherichia coli. PLOS Computational Biology. 2012;8:e1002811. doi: 10.1371/journal.pcbi.1002811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brewster RC, Weinert FM, Garcia HG, Song D, Rydenfelt M, Phillips R. The transcription factor titration effect dictates level of gene expression. Cell. 2014;156:1312–1323. doi: 10.1016/j.cell.2014.02.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Browning DF, Busby SJ. Local and global regulation of transcription initiation in bacteria. Nature Reviews Microbiology. 2016;14:638–650. doi: 10.1038/nrmicro.2016.103. [DOI] [PubMed] [Google Scholar]
- Busby S, Ebright RH. Transcription activation by catabolite activator protein (CAP) Journal of Molecular Biology. 1999;293:199–213. doi: 10.1006/jmbi.1999.3161. [DOI] [PubMed] [Google Scholar]
- Courey AJ. Mechanisms in Transcriptional Regulation. Malden, MA: Blackwell; 2008. [Google Scholar]
- Cui L, Murchland I, Shearwin KE, Dodd IB. Enhancer-like long-range transcriptional activation by λ CI-mediated DNA looping. PNAS. 2013;110:2922–2927. doi: 10.1073/pnas.1221322110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ebright RH, Ebright YW, Gunasekera A. Consensus DNA site for the Escherichia coli catabolite gene activator protein (CAP): CAP exhibits a 450-fold higher affinity for the consensus DNA site than for the E. coli lac DNA site. Nucleic Acids Research. 1989;17:10295–10305. doi: 10.1093/nar/17.24.10295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Einav T, Duque J, Phillips R. Theoretical analysis of inducer and operator binding for cyclic-AMP receptor protein mutants. PLOS ONE. 2018;13:e0204275. doi: 10.1371/journal.pone.0204275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foat BC, Morozov AV, Bussemaker HJ. Statistical mechanical modeling of genome-wide transcription factor occupancy data by MatrixREDUCE. Bioinformatics. 2006;22:e141–e149. doi: 10.1093/bioinformatics/btl223. [DOI] [PubMed] [Google Scholar]
- Forcier TL, Kinney JB. Supplemental Code for Forcier et al., 2018. 602ca57GitHub. 2018 https://github.com/jbkinney/17_inducibility
- Garcia HG, Phillips R. Quantitative dissection of the simple repression input-output function. PNAS. 2011;108:12173–12178. doi: 10.1073/pnas.1015616108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaston K, Bell A, Kolb A, Buc H, Busby S. Stringent spacing requirements for transcription activation by CRP. Cell. 1990;62:733–743. doi: 10.1016/0092-8674(90)90118-X. [DOI] [PubMed] [Google Scholar]
- Gertz J, Siggia ED, Cohen BA. Analysis of combinatorial cis-regulation in synthetic and genomic promoters. Nature. 2009;457:215–218. doi: 10.1038/nature07521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gunasekera A, Ebright YW, Ebright RH. DNA sequence determinants for binding of the Escherichia coli catabolite gene activator protein. The Journal of Biological Chemistry. 1992;267:14713–14720. [PubMed] [Google Scholar]
- Keseler IM, Collado-Vides J, Santos-Zavaleta A, Peralta-Gil M, Gama-Castro S, Muniz-Rascado L, Bonavides-Martinez C, Paley S, Krummenacker M, Altman T, Kaipa P, Spaulding A, Pacheco J, Latendresse M, Fulcher C, Sarker M, Shearer AG, Mackie A, Paulsen I, Gunsalus RP, Karp PD. EcoCyc: a comprehensive database of Escherichia coli biology. Nucleic Acids Research. 2011;39:D583–D590. doi: 10.1093/nar/gkq1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kinney JB, Murugan A, Callan CG, Cox EC. Using deep sequencing to characterize the biophysical mechanism of a transcriptional regulatory sequence. PNAS. 2010;107:9158–9163. doi: 10.1073/pnas.1004290107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuhlman T, Zhang Z, Saier MH, Hwa T. Combinatorial transcriptional control of the lactose operon of Escherichia coli. PNAS. 2007;104:6043–6048. doi: 10.1073/pnas.0606717104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kwasnieski JC, Mogno I, Myers CA, Corbo JC, Cohen BA. Complex effects of nucleotide variants in a mammalian cis-regulatory element. PNAS. 2012;109:19498–19503. doi: 10.1073/pnas.1210678109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lederberg J. The beta-d-galactosidase of Escherichia coli, strain K-12. Journal of Bacteriology. 1950;60:381–392. doi: 10.1128/jb.60.4.381-392.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee DJ, Minchin SD, Busby SJ. Activating transcription in bacteria. Annual Review of Microbiology. 2012;66:125–152. doi: 10.1146/annurev-micro-092611-150012. [DOI] [PubMed] [Google Scholar]
- Levo M, Segal E. In pursuit of design principles of regulatory sequences. Nature Reviews Genetics. 2014;15:453–468. doi: 10.1038/nrg3684. [DOI] [PubMed] [Google Scholar]
- Malan TP, Kolb A, Buc H, McClure WR. Mechanism of CRP-cAMP activation of lac operon transcription initiation activation of the P1 promoter. Journal of Molecular Biology. 1984;180:881–909. doi: 10.1016/0022-2836(84)90262-6. [DOI] [PubMed] [Google Scholar]
- Markovitch O, Agmon N. Structure and energetics of the hydronium hydration shells. The Journal of Physical Chemistry A. 2007;111:2253–2256. doi: 10.1021/jp068960g. [DOI] [PubMed] [Google Scholar]
- McClure WR, Hawley DK, Youderian P, Susskind MM. DNA determinants of promoter selectivity in Escherichia coli. Cold Spring Harbor Symposia on Quantitative Biology. 1983;47:477–481. doi: 10.1101/SQB.1983.047.01.057. [DOI] [PubMed] [Google Scholar]
- Melnikov A, Murugan A, Zhang X, Tesileanu T, Wang L, Rogov P, Feizi S, Gnirke A, Callan CG, Kinney JB, Kellis M, Lander ES, Mikkelsen TS. Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nature Biotechnology. 2012;30:271–277. doi: 10.1038/nbt.2137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller J. Experiments in Molecular Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1972. [Google Scholar]
- Mogno I, Kwasnieski JC, Cohen BA. Massively parallel synthetic promoter assays reveal the in vivo effects of binding site variants. Genome Research. 2013;23:1908–1915. doi: 10.1101/gr.157891.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morita T, Shigesada K, Kimizuka F, Aiba H. Regulatory effect of a synthetic CRP recognition sequence placed downstream of a promoter. Nucleic Acids Research. 1988;16:7315–7332. doi: 10.1093/nar/16.15.7315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neidhardt FC, Bloch PL, Smith DF. Culture medium for enterobacteria. Journal of Bacteriology. 1974;119:736–747. doi: 10.1128/jb.119.3.736-747.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Niu W, Kim Y, Tau G, Heyduk T, Ebright RH. Transcription activation at class II CAP-dependent promoters: two interactions between CAP and RNA polymerase. Cell. 1996;87:1123–1134. doi: 10.1016/S0092-8674(00)81806-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parkinson G, Wilson C, Gunasekera A, Ebright YW, Ebright RH, Ebright RE, Berman HM. Structure of the CAP-DNA complex at 2.5 angstroms resolution: a complete picture of the protein-DNA interface. Journal of Molecular Biology. 1996;260:395–408. doi: 10.1006/jmbi.1996.0409. [DOI] [PubMed] [Google Scholar]
- Patwardhan RP, Hiatt JB, Witten DM, Kim MJ, Smith RP, May D, Lee C, Andrie JM, Lee SI, Cooper GM, Ahituv N, Pennacchio LA, Shendure J. Massively parallel functional dissection of mammalian enhancers in vivo. Nature Biotechnology. 2012;30:265–270. doi: 10.1038/nbt.2136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pribnow D. Nucleotide sequence of an RNA polymerase binding site at an early T7 promoter. PNAS. 1975;72:784–788. doi: 10.1073/pnas.72.3.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ptashne M, Gann A. Genes and Signals. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2002. [Google Scholar]
- Ptashne M. Regulated recruitment and cooperativity in the design of biological regulatory systems. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences. 2003;361:1223–1234. doi: 10.1098/rsta.2003.1195. [DOI] [PubMed] [Google Scholar]
- Reznikoff WS. The lactose operon-controlling elements: a complex paradigm. Molecular Microbiology. 1992;6:2419–2422. doi: 10.1111/j.1365-2958.1992.tb01416.x. [DOI] [PubMed] [Google Scholar]
- Rhodius VA, West DM, Webster CL, Busby SJ, Savery NJ. Transcription activation at class II CRP-dependent promoters: the role of different activating regions. Nucleic Acids Research. 1997;25:326–332. doi: 10.1093/nar/25.2.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roy S, Garges S, Adhya S. Activation and repression of transcription by differential contact: two sides of a coin. Journal of Biological Chemistry. 1998;273:14059–14062. doi: 10.1074/jbc.273.23.14059. [DOI] [PubMed] [Google Scholar]
- Salgado H, Peralta-Gil M, Gama-Castro S, Santos-Zavaleta A, Muñiz-Rascado L, García-Sotelo JS, Weiss V, Solano-Lira H, Martínez-Flores I, Medina-Rivera A, Salgado-Osorio G, Alquicira-Hernández S, Alquicira-Hernández K, López-Fuentes A, Porrón-Sotelo L, Huerta AM, Bonavides-Martínez C, Balderas-Martínez YI, Pannier L, Olvera M, Labastida A, Jiménez-Jacinto V, Vega-Alvarado L, Del Moral-Chávez V, Hernández-Alvarez A, Morett E, Collado-Vides J. RegulonDB v8.0: omics data sets, evolutionary conservation, regulatory phrases, cross-validated gold standards and more. Nucleic Acids Research. 2013;41:D203–D213. doi: 10.1093/nar/gks1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmidt A, Kochanowski K, Vedelaar S, Ahrné E, Volkmer B, Callipo L, Knoops K, Bauer M, Aebersold R, Heinemann M. The quantitative and condition-dependent Escherichia coli proteome. Nature Biotechnology. 2016;34:104–110. doi: 10.1038/nbt.3418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sharon E, Kalma Y, Sharp A, Raveh-Sadka T, Levo M, Zeevi D, Keren L, Yakhini Z, Weinberger A, Segal E. Inferring gene regulatory logic from high-throughput measurements of thousands of systematically designed promoters. Nature Biotechnology. 2012;30:521–530. doi: 10.1038/nbt.2205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shea MA, Ackers GK. The OR control system of bacteriophage lambda. A physical-chemical model for gene regulation. Journal of Molecular Biology. 1985;181:211–230. doi: 10.1016/0022-2836(85)90086-5. [DOI] [PubMed] [Google Scholar]
- Sherman MS, Cohen BA. Thermodynamic state ensemble models of cis-regulation. PLOS Computational Biology. 2012;8:e1002407. doi: 10.1371/journal.pcbi.1002407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith RP, Taher L, Patwardhan RP, Kim MJ, Inoue F, Shendure J, Ovcharenko I, Ahituv N. Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model. Nature Genetics. 2013;45:1021–1028. doi: 10.1038/ng.2713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- So LH, Ghosh A, Zong C, Sepúlveda LA, Segev R, Golding I. General properties of transcriptional time series in Escherichia coli. Nature Genetics. 2011;43:554–560. doi: 10.1038/ng.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spitz F, Furlong EE. Transcription factors: from enhancer binding to developmental control. Nature Reviews Genetics. 2012;13:613–626. doi: 10.1038/nrg3207. [DOI] [PubMed] [Google Scholar]
- Thompson MG, Sedaghatian N, Barajas JF, Wehrs M, Bailey CB, Kaplan N, Hillson NJ, Mukhopadhyay A, Keasling JD. Isolation and characterization of novel mutations in the pSC101 origin that increase copy number. Scientific Reports. 2018;8:1590. doi: 10.1038/s41598-018-20016-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ushida C, Aiba H. Helical phase dependent action of CRP: effect of the distance between the CRP site and the -35 region on promoter activity. Nucleic Acids Research. 1990;18:6325–6330. doi: 10.1093/nar/18.21.6325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vilar JM, Leibler S. DNA looping and physical constraints on transcription regulation. Journal of Molecular Biology. 2003;331:981–989. doi: 10.1016/S0022-2836(03)00764-2. [DOI] [PubMed] [Google Scholar]
- Weingarten-Gabbay S, Nir R, Lubliner S, Sharon E, Kalma Y, Weinberger A, Segal E. Deciphering transcriptional regulation of human core promoters. bioRxiv. 2017 doi: 10.1101/174904. [DOI]
- White MA, Kwasnieski JC, Myers CA, Shen SQ, Corbo JC, Cohen BA. A simple grammar defines activating and repressing cis-regulatory elements in photoreceptors. Cell Reports. 2016;17:1247–1254. doi: 10.1016/j.celrep.2016.09.066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wong MS, Kinney JB, Krainer AR. Quantitative activity profile and context dependence of all human 5' splice sites. Molecular Cell. 2018;71:1012–1026. doi: 10.1016/j.molcel.2018.07.033. [DOI] [PMC free article] [PubMed] [Google Scholar]